14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2006:T082106.20061113|
|Date of decision:||13 November 2006|
|Case number:||T 0821/06|
|IPC class:||A61K 35/74|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Inhibition of Pathogens by Bacillus Coagulans Strains|
|Applicant name:||Ganeden Biotech, Inc.|
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
The appeal contests the decision of the Examining Division of the European Patent Office dated 20 December 2005 concerning refusal of the European Patent application No. 00 978 435.6.
The appellant (applicant) filed a notice of appeal on 28 February 2006 and paid the fee for appeal on the same day.
No statement of grounds was filed by the appellant.
The notice of appeal contains nothing that could be regarded as a statement of grounds pursuant to Article 108 EPC.
By communications dated 9 August 2006, sent by registered letter with advice of delivery, the registry of the Board informed the appellant that no statement of grounds had been filed and that the appeal could be expected to be rejected as inadmissible.
The appellant was invited to file observations within two months.
Attention was also drawn to Article 122 EPC.
In response to an inquiry by the registry of the Board, the representative of the appellant confirmed that no response had been or would be filed to the communication of 9 August 2006.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed, the appeal has to be rejected as inadmissible (Rule 65(1) EPC in conjunction with Article 108 EPC).
For these reasons it is decided that:
The appeal is rejected as inadmissible